— Know what they know.
Not Investment Advice
Also trades as: BSX (NYSE) · $vol 910M · BSX-PA (NYSE) · $vol 22M · 0HOY.L (LSE) · $vol 2M

BSX.F FSX

Boston Scientific Corporation
1W: +6.8% 1M: -9.9% 3M: -21.8% YTD: -21.8% 1Y: -42.5% 3Y: +4.0% 5Y: +36.0%
€48.70 ($56.62)
-0.02 (-0.04%)
 
Weekly Expected Move ±6.5%
€39 €42 €45 €48 €51
FSX · Healthcare · Medical - Devices · Alpha Radar Sell · Power 51 · €72.4B mcap · 1.48B float · 0.0000% daily turnover
Smart Money Score
No convergence signal
Key Statistics
Market Cap€72.4B ($84.2B)
52W Range44.89-94.4
Volume445
Avg Volume367
Beta0.62
Dividend
Analyst Ratings
40 Buy 3 Hold 0 Sell
Consensus Buy
Company Info
CEOMichael F. Mahoney
Employees53,000
SectorHealthcare
IndustryMedical - Devices
IPO Date2000-01-03
300 Boston Scientific Way
Marlborough, MA 01752-1234
US
508 683 4000
About Boston Scientific Corporation

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through MedSurg and Cardiovascular segments. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, that uses in the treatment of coronary artery disease and aortic valve conditions. Further, it provides stents, balloon catheters, guidewires, atherectomy, and thrombectomy systems to treat arterial and venous diseases; and peripheral embolization devices, radioactive microspheres, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms